Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.
Sharzad EmamikiaShereen OonAlvaro GomezJulius LindblomAlexander BorgYvonne EnmanEric F MorandDavid GrannasRonald F van VollenhovenMandana NikpourIoannis ParodisPublished in: Rheumatology (Oxford, England) (2022)
Remission and LLDAS contribute to a HRQoL benefit in a time-dependent manner. Shorter time in remission than in LLDAS was required for a clinically important benefit in HRQoL, and longer time in remission for a benefit in mental compared with physical HRQoL aspects. When remission/LLDAS was sustained, the same benefit was achieved in a shorter time.